{"id":922,"date":"2023-09-29T22:29:45","date_gmt":"2023-09-29T22:29:45","guid":{"rendered":"https:\/\/pyrameshealth.com\/?p=922"},"modified":"2023-10-02T16:53:41","modified_gmt":"2023-10-02T16:53:41","slug":"pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device","status":"publish","type":"post","link":"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/","title":{"rendered":"PyrAmes Receives FDA Clearance for its Groundbreaking Boppli<\/sup>\u00ae<\/sup> Wearable Blood Pressure Monitoring Device"},"content":{"rendered":"<h3><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-924 alignleft\" src=\"https:\/\/pyrameshealth.com\/wp-content\/uploads\/2023\/09\/PyrAmes-Boppli-300x245.jpg\" alt=\"\" width=\"227\" height=\"185\" srcset=\"https:\/\/pyrameshealth.com\/wp-content\/uploads\/2023\/09\/PyrAmes-Boppli-300x245.jpg 300w, https:\/\/pyrameshealth.com\/wp-content\/uploads\/2023\/09\/PyrAmes-Boppli-1024x838.jpg 1024w, https:\/\/pyrameshealth.com\/wp-content\/uploads\/2023\/09\/PyrAmes-Boppli-768x628.jpg 768w, https:\/\/pyrameshealth.com\/wp-content\/uploads\/2023\/09\/PyrAmes-Boppli.jpg 1523w\" sizes=\"(max-width: 227px) 100vw, 227px\" \/><\/h3>\n<h2><em style=\"font-size: 16px;\">Boppli provides essential clinical information for newborns undergoing critical care<\/em><\/h2>\n<p>Cupertino, CA, September 29, 2023 \u2014 PyrAmes Inc., a digital health company pioneering innovative blood pressure (BP) monitoring solutions, today announced it has received FDA 510(k) clearance for its revolutionary Boppli<sup>\u00ae <\/sup>platform to continuously and non-invasively monitor the blood pressure of critically-ill infants. <strong>Boppli offers safe and accurate BP monitoring as an alternative to invasive arterial lines (IAL) and intermittent cuff-based measurements.<\/strong> Boppli previously received Breakthrough Device Designation from the FDA, recognizing its potential to enable more timely identification of life-threatening conditions. It is the only commercially-available, continuous and non-invasive BP monitoring solution for infants.<\/p>\n<p>Boppli improves ease of use and avoids the risks and costs associated with IALs. Boppli also eliminates the cumbersome and time-consuming nature of standard cuff-based measurements, which provide only occasional spot BP values and may be prone to inaccuracies. Boppli accuracy was demonstrated to be within FDA guidelines during a rigorous, pivotal clinical study by comparing Boppli sensor data against simultaneous IAL data for critically ill infants in multiple neonatal intensive care units (NICU) in the U.S. and Canada.<\/p>\n<p><!--more--><\/p>\n<p>\u201cBoppli will provide us with the ability to non-invasively and continuously monitor blood pressure in our tiny, fragile babies \u2013 accurately and without disturbing them,\u201d said Lamia Soghier, MD, MEd, MBA, Medical Director and Quality &amp; Safety Officer of the NICU at Children\u2019s National Hospital. \u201cThis is a game-changer, as we no longer have to worry about spending time sticking infants multiple times in multiple places to put in an arterial line. I am also excited that we will avoid arterial line complications. As a clinician who has seen terrible loss of fingers from thrombosis of arterial lines, I am thrilled that we now have a safer modality. We will be able to place Boppli quickly, even for our tiny 500g infants. As one of the centers in PyrAmes\u2019 clinical study, we saw first-hand the value that Boppli provided to medical care in the NICU.\u201d<\/p>\n<p>Boppli integrates capacitive sensors that are placed on the arm and\/or leg of infants to acquire pulse waveform measurements. The systolic, diastolic, and mean arterial pressures are then inferred from the recorded pulse waveform data using algorithms trained with artificial neural network techniques.<\/p>\n<p>\u201cWe are excited to have Boppli, our company\u2019s first product, cleared by the FDA,\u201d said Xina Quan, Ph.D., PyrAmes Co-founder and CEO. \u201cDetecting clinically-important blood pressure information in a safe and timely way with a non-invasive approach has the potential to provide life-changing clinical information for hundreds of thousands of fragile babies without the risks and costs of today\u2019s standards of care.\u201d<\/p>\n<p>\u201cAs PyrAmes&#8217; commercial partner, we are excited to introduce these innovative products, empowering NICU doctors and nurses with Boppli&#8217;s first-of-its kind Non-Invasive Blood Pressure technology,&#8221; stated Bob Cormier, President of Sentec North America. &#8220;Boppli addresses a crucial need in non-invasive monitoring for neonatal patients, potentially transforming the well-being of these delicate, precious patients.&#8221;<\/p>\n<p>Boppli\u2019s FDA market clearance represents a first step in PyrAmes\u2019 robust product roadmap to enable more convenient, clinically-accurate, blood pressure monitoring for inpatients and outpatients of all ages, beginning with babies and their mothers to support their health before and after childbirth.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boppli provides essential clinical information for newborns undergoing critical care Cupertino, CA, September 29, 2023 \u2014 PyrAmes Inc., a digital health company pioneering innovative blood pressure (BP) monitoring solutions, today announced it has received FDA 510(k) clearance for its revolutionary Boppli\u00ae platform to continuously and non-invasively monitor the blood pressure of critically-ill infants. Boppli offers [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":4,"featured_media":380,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[17],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PyrAmes Receives FDA Clearance for its Groundbreaking Boppli\u00ae Wearable Blood Pressure Monitoring Device - PyrAmes<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PyrAmes Receives FDA Clearance for its Groundbreaking Boppli\u00ae Wearable Blood Pressure Monitoring Device - PyrAmes\" \/>\n<meta property=\"og:description\" content=\"Boppli provides essential clinical information for newborns undergoing critical care Cupertino, CA, September 29, 2023 \u2014 PyrAmes Inc., a digital health company pioneering innovative blood pressure (BP) monitoring solutions, today announced it has received FDA 510(k) clearance for its revolutionary Boppli\u00ae platform to continuously and non-invasively monitor the blood pressure of critically-ill infants. Boppli offers [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/\" \/>\n<meta property=\"og:site_name\" content=\"PyrAmes\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-29T22:29:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-02T16:53:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pyrameshealth.com\/wp-content\/uploads\/2021\/04\/boppli-hero-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1003\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Keith Drake\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Keith Drake\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/\"},\"author\":{\"name\":\"Keith Drake\",\"@id\":\"https:\/\/pyrameshealth.com\/#\/schema\/person\/b8e05f3303cb0ef25114d5e385b78efc\"},\"headline\":\"PyrAmes Receives FDA Clearance for its Groundbreaking Boppli\u00ae Wearable Blood Pressure Monitoring Device\",\"datePublished\":\"2023-09-29T22:29:45+00:00\",\"dateModified\":\"2023-10-02T16:53:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/\"},\"wordCount\":545,\"publisher\":{\"@id\":\"https:\/\/pyrameshealth.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pyrameshealth.com\/wp-content\/uploads\/2021\/04\/boppli-hero-1.jpg\",\"articleSection\":[\"news\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/\",\"url\":\"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/\",\"name\":\"PyrAmes Receives FDA Clearance for its Groundbreaking Boppli\u00ae Wearable Blood Pressure Monitoring Device - PyrAmes\",\"isPartOf\":{\"@id\":\"https:\/\/pyrameshealth.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pyrameshealth.com\/wp-content\/uploads\/2021\/04\/boppli-hero-1.jpg\",\"datePublished\":\"2023-09-29T22:29:45+00:00\",\"dateModified\":\"2023-10-02T16:53:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/#primaryimage\",\"url\":\"https:\/\/pyrameshealth.com\/wp-content\/uploads\/2021\/04\/boppli-hero-1.jpg\",\"contentUrl\":\"https:\/\/pyrameshealth.com\/wp-content\/uploads\/2021\/04\/boppli-hero-1.jpg\",\"width\":1920,\"height\":1003,\"caption\":\"boppli-hero\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pyrameshealth.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PyrAmes Receives FDA Clearance for its Groundbreaking Boppli\u00ae Wearable Blood Pressure Monitoring Device\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pyrameshealth.com\/#website\",\"url\":\"https:\/\/pyrameshealth.com\/\",\"name\":\"PyrAmes\",\"description\":\"Vital data, innovative care.\",\"publisher\":{\"@id\":\"https:\/\/pyrameshealth.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pyrameshealth.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/pyrameshealth.com\/#organization\",\"name\":\"PyrAmes\",\"url\":\"https:\/\/pyrameshealth.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pyrameshealth.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/pyrameshealth.com\/wp-content\/uploads\/2022\/03\/cropped-PyrAmes_Logo_new_small-4.jpg\",\"contentUrl\":\"https:\/\/pyrameshealth.com\/wp-content\/uploads\/2022\/03\/cropped-PyrAmes_Logo_new_small-4.jpg\",\"width\":459,\"height\":135,\"caption\":\"PyrAmes\"},\"image\":{\"@id\":\"https:\/\/pyrameshealth.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/pyrameshealth.com\/#\/schema\/person\/b8e05f3303cb0ef25114d5e385b78efc\",\"name\":\"Keith Drake\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pyrameshealth.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1c8d8599f9b9bcc3bd5f9fd09a18297c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1c8d8599f9b9bcc3bd5f9fd09a18297c?s=96&d=mm&r=g\",\"caption\":\"Keith Drake\"},\"url\":\"https:\/\/pyrameshealth.com\/author\/keithadmin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PyrAmes Receives FDA Clearance for its Groundbreaking Boppli\u00ae Wearable Blood Pressure Monitoring Device - PyrAmes","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/","og_locale":"en_US","og_type":"article","og_title":"PyrAmes Receives FDA Clearance for its Groundbreaking Boppli\u00ae Wearable Blood Pressure Monitoring Device - PyrAmes","og_description":"Boppli provides essential clinical information for newborns undergoing critical care Cupertino, CA, September 29, 2023 \u2014 PyrAmes Inc., a digital health company pioneering innovative blood pressure (BP) monitoring solutions, today announced it has received FDA 510(k) clearance for its revolutionary Boppli\u00ae platform to continuously and non-invasively monitor the blood pressure of critically-ill infants. Boppli offers [...]Read More...","og_url":"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/","og_site_name":"PyrAmes","article_published_time":"2023-09-29T22:29:45+00:00","article_modified_time":"2023-10-02T16:53:41+00:00","og_image":[{"width":1920,"height":1003,"url":"https:\/\/pyrameshealth.com\/wp-content\/uploads\/2021\/04\/boppli-hero-1.jpg","type":"image\/jpeg"}],"author":"Keith Drake","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Keith Drake","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/#article","isPartOf":{"@id":"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/"},"author":{"name":"Keith Drake","@id":"https:\/\/pyrameshealth.com\/#\/schema\/person\/b8e05f3303cb0ef25114d5e385b78efc"},"headline":"PyrAmes Receives FDA Clearance for its Groundbreaking Boppli\u00ae Wearable Blood Pressure Monitoring Device","datePublished":"2023-09-29T22:29:45+00:00","dateModified":"2023-10-02T16:53:41+00:00","mainEntityOfPage":{"@id":"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/"},"wordCount":545,"publisher":{"@id":"https:\/\/pyrameshealth.com\/#organization"},"image":{"@id":"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/#primaryimage"},"thumbnailUrl":"https:\/\/pyrameshealth.com\/wp-content\/uploads\/2021\/04\/boppli-hero-1.jpg","articleSection":["news"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/","url":"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/","name":"PyrAmes Receives FDA Clearance for its Groundbreaking Boppli\u00ae Wearable Blood Pressure Monitoring Device - PyrAmes","isPartOf":{"@id":"https:\/\/pyrameshealth.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/#primaryimage"},"image":{"@id":"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/#primaryimage"},"thumbnailUrl":"https:\/\/pyrameshealth.com\/wp-content\/uploads\/2021\/04\/boppli-hero-1.jpg","datePublished":"2023-09-29T22:29:45+00:00","dateModified":"2023-10-02T16:53:41+00:00","breadcrumb":{"@id":"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/#primaryimage","url":"https:\/\/pyrameshealth.com\/wp-content\/uploads\/2021\/04\/boppli-hero-1.jpg","contentUrl":"https:\/\/pyrameshealth.com\/wp-content\/uploads\/2021\/04\/boppli-hero-1.jpg","width":1920,"height":1003,"caption":"boppli-hero"},{"@type":"BreadcrumbList","@id":"https:\/\/pyrameshealth.com\/pyrames-receives-fda-clearance-for-its-groundbreaking-bopplir-wearable-blood-pressure-monitoring-device\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pyrameshealth.com\/"},{"@type":"ListItem","position":2,"name":"PyrAmes Receives FDA Clearance for its Groundbreaking Boppli\u00ae Wearable Blood Pressure Monitoring Device"}]},{"@type":"WebSite","@id":"https:\/\/pyrameshealth.com\/#website","url":"https:\/\/pyrameshealth.com\/","name":"PyrAmes","description":"Vital data, innovative care.","publisher":{"@id":"https:\/\/pyrameshealth.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pyrameshealth.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pyrameshealth.com\/#organization","name":"PyrAmes","url":"https:\/\/pyrameshealth.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pyrameshealth.com\/#\/schema\/logo\/image\/","url":"https:\/\/pyrameshealth.com\/wp-content\/uploads\/2022\/03\/cropped-PyrAmes_Logo_new_small-4.jpg","contentUrl":"https:\/\/pyrameshealth.com\/wp-content\/uploads\/2022\/03\/cropped-PyrAmes_Logo_new_small-4.jpg","width":459,"height":135,"caption":"PyrAmes"},"image":{"@id":"https:\/\/pyrameshealth.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pyrameshealth.com\/#\/schema\/person\/b8e05f3303cb0ef25114d5e385b78efc","name":"Keith Drake","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pyrameshealth.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1c8d8599f9b9bcc3bd5f9fd09a18297c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1c8d8599f9b9bcc3bd5f9fd09a18297c?s=96&d=mm&r=g","caption":"Keith Drake"},"url":"https:\/\/pyrameshealth.com\/author\/keithadmin\/"}]}},"_links":{"self":[{"href":"https:\/\/pyrameshealth.com\/wp-json\/wp\/v2\/posts\/922"}],"collection":[{"href":"https:\/\/pyrameshealth.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pyrameshealth.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pyrameshealth.com\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pyrameshealth.com\/wp-json\/wp\/v2\/comments?post=922"}],"version-history":[{"count":0,"href":"https:\/\/pyrameshealth.com\/wp-json\/wp\/v2\/posts\/922\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pyrameshealth.com\/wp-json\/wp\/v2\/media\/380"}],"wp:attachment":[{"href":"https:\/\/pyrameshealth.com\/wp-json\/wp\/v2\/media?parent=922"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pyrameshealth.com\/wp-json\/wp\/v2\/categories?post=922"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pyrameshealth.com\/wp-json\/wp\/v2\/tags?post=922"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}